Evidence map›Paper›PMID 37228664›Full record

ReviewFrontiers in cellular and infection microbiology2023

A review of malaria molecular markers for drug resistance in

Siqi Wang, Fang Huang, He Yan, Jianhai Yin, Zhigui Xia

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Total Synthesis of Tosyl-Samroiyotmycin A and Its Biological Profiling.Chemistry (Weinheim an der Bergstrasse, Germany) · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Siqi WangNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.
Fang HuangShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
He YanNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.
Jianhai YinNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.
Zhigui XiaNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.
National Institute for Parasitic Diseases · CNShanghai Municipal Center For Disease Control Prevention · CN

Funding

Bill & Melinda Gates Foundation INV-018913
6 · The paper itself

Abstract

China has now achieved the elimination of malaria, but it still faces severe challenges in the post-elimination stage. China continues to be plagued by imported malaria cases, and preventing re-transmission of imported malaria is critical. The effectiveness of antimalarial drugs for malaria control largely depends on the study of drug resistance markers

Indexed as

MalariaMalaria, FalciparumChinaDrug ResistanceHumansPlasmodium falciparumPlasmodium vivaxProtozoan ProteinsSystematic Reviews as TopicProtozoan ProteinsChinagenePlasmodium falciparumPlasmodium vivaxpolymorphism

Identifiers

PMID37228664
PMCPMC10203619
OpenAlexW4378348205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.